North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

September 2022 | 143 pages | ID: N77CF84123F8EN
GMD Research

Abstracts

North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ 6,153.0 million by 2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.

Highlighted with 29 tables and 73 figures, this 143-page report “North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Consumables
• Software

Based on Omics Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Single Cell Genomics (SCG)
• Single Cell Transcriptomics (SCT)
• Single Cell Proteomics (SCP)
• Single Cell Metabolomics (SCM)

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Clinical Research
• Oncology
• Cell Therapy
• Immunology
• Neurology
• Cell Biology
• Other Types of Clinical Research
• Translation Research
• Synthetic Biology

By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Human Samples
• Cancer Tissues
• Stem Cells
• Immune Cells
• Brain Cells
• Other Human Samples
• Animal Samples
• Microbial Samples

By Workflow, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Single-Cell Isolation and Dispensing
• Fluorescence-Activated Cell Sorting (FACS)
• Microfluidics
• Magnetic-Activated Cell Sorting (MACS)
• Random Seeding
• Manual Cell Picking
• Laser Capture Microdissection
• Other Technologies of Single-Cell Isolation and Dispensing
• Single-Cell Analysis
• Polymerase Chain Reaction
• Next-Generation Sequencing
• Mass Cytometry
• Mass Spectrometry
• Other Technologies of Single-Cell Analysis

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Research and Academic Laboratories
• Biopharmaceutical and Biotech Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

10x Genomics, Inc.

1CellBio, Inc.

Becton, Dickinson and Company

Berkeley Lights, Inc.

BGI Genomics Co., Ltd.

Bio-Rad Laboratories, Inc.

Bio-Techne Corporation

BioTuring, Inc.

Danaher Corporation (Cytiva Life Sciences)

Dolomite Bio

Fluidigm Corporation

Fluxion Biosciences

Illimina, Inc

Mission Bio, Inc.

Namocell, Inc.

NanoString Technologies, Inc.

Parse Biosciences, Inc.

Proteona

Qiagen N.V.

RareCyte, Inc.

Scipio Biosciences SAS

Shilps Sciences

Takara Bio Inc. (Takara Holdings)

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Instruments
3.3 Consumables
3.4 Software

4 SEGMENTATION OF NORTH AMERICA MARKET BY OMICS TYPE

4.1 Market Overview by Omics Type
4.2 Single Cell Genomics (SCG)
4.3 Single Cell Transcriptomics (SCT)
4.4 Single Cell Proteomics (SCP)
4.5 Single Cell Metabolomics (SCM)

5 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Clinical Research
  5.2.1 Oncology
  5.2.2 Cell Therapy
  5.2.3 Immunology
  5.2.4 Neurology
  5.2.5 Cell Biology
  5.2.6 Other Types of Clinical Research
5.3 Translation Research
5.4 Synthetic Biology

6 SEGMENTATION OF NORTH AMERICA MARKET BY SAMPLE TYPE

6.1 Market Overview by Sample Type
6.2 Human Samples
  6.2.1 Cancer Tissues
  6.2.2 Stem Cells
  6.2.3 Immune Cells
  6.2.4 Brain Cells
  6.2.5 Other Human Samples
6.3 Animal Samples
6.4 Microbial Samples

7 SEGMENTATION OF NORTH AMERICA MARKET BY WORKFLOW

7.1 Market Overview by Workflow
7.2 Single-Cell Isolation and Dispensing
  7.2.1 Fluorescence-Activated Cell Sorting (FACS)
  7.2.2 Microfluidics
  7.2.3 Magnetic-Activated Cell Sorting (MACS)
  7.2.4 Random Seeding
  7.2.5 Manual Cell Picking
  7.2.6 Laser Capture Microdissection
  7.2.7 Other Technologies of Single-Cell Isolation and Dispensing
7.3 Single-Cell Analysis
  7.3.1 Polymerase Chain Reaction
  7.3.2 Next-Generation Sequencing
  7.3.3 Mass Cytometry
  7.3.4 Mass Spectrometry
  7.3.5 Other Technologies of Single-Cell Analysis

8 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

8.1 Market Overview by End User
8.2 Research and Academic Laboratories
8.3 Biopharmaceutical and Biotech Companies
8.4 Contract Research Organizations (CROs)
8.5 Other End Users

9 NORTH AMERICA MARKET 2021-2031 BY COUNTRY

9.1 Overview of North America Market
9.2 U.S.
9.3 Canada
9.4 Mexico

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles

10X GENOMICS, INC.

1CELLBIO, INC.

Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of North America Single Cell Multiomics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Comparison of Rare Disease in Different Countries
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in North America Single Cell Multiomics Market
Table 7. North America Single Cell Multiomics Market by Product Type, 2021-2031, $ mn
Table 8. North America Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 9. North America Single Cell Multiomics Market by Application, 2021-2031, $ mn
Table 10. North America Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn
Table 11. North America Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn
Table 12. North America Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn
Table 13. North America Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 14. North America Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn
Table 15. North America Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn
Table 16. North America Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 17. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn
Table 18. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 19. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 20. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 21. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 22. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 23. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 24. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn
Table 25. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn
Table 26. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn
Table 27. 10x Genomics, Inc.: Company Snapshot
Table 28. 10x Genomics, Inc.: Business Segmentation
Table 29. 10x Genomics, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. North America Single Cell Multiomics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Single Cell Multiomics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of North America Single Cell Multiomics Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of North America Single Cell Multiomics Market
Figure 14. Breakdown of North America Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue
Figure 15. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)
Figure 16. North America Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn
Figure 17. North America Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn
Figure 18. North America Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn
Figure 19. Breakdown of North America Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue
Figure 20. North America Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)
Figure 21. North America Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn
Figure 22. North America Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn
Figure 23. North America Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn
Figure 24. North America Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn
Figure 25. Breakdown of North America Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue
Figure 26. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 27. North America Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn
Figure 28. North America Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn
Figure 29. North America Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn
Figure 30. North America Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn
Figure 31. North America Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn
Figure 32. North America Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn
Figure 33. North America Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn
Figure 34. North America Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn
Figure 35. North America Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn
Figure 36. Breakdown of North America Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue
Figure 37. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)
Figure 38. North America Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn
Figure 39. North America Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn
Figure 40. North America Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn
Figure 41. North America Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn
Figure 42. North America Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn
Figure 43. North America Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn
Figure 44. North America Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn
Figure 45. North America Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn
Figure 46. Breakdown of North America Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue
Figure 47. North America Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)
Figure 48. North America Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn
Figure 49. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn
Figure 50. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn
Figure 51. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn
Figure 52. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn
Figure 53. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn
Figure 54. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn
Figure 55. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn
Figure 56. North America Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn
Figure 57. North America Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn
Figure 58. North America Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn
Figure 59. North America Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn
Figure 60. North America Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn
Figure 61. North America Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn
Figure 62. Breakdown of North America Single Cell Multiomics Market by End User, 2021-2031, % of Revenue
Figure 63. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 64. North America Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn
Figure 65. North America Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn
Figure 66. North America Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 67. North America Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn
Figure 68. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue
Figure 69. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 70. U.S. Single Cell Multiomics Market, 2021-2031, $ mn
Figure 71. Canada Single Cell Multiomics Market, 2021-2031, $ mn
Figure 72. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn
Figure 73. Growth Stage of North America Single Cell Multiomics Industry over the Forecast Period